Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Boehringer Ingelheim Limited

Boehringer Ingelheim announces succession Chairmen Shareholders’ Committee and Board of Managing Directors
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer Ingelheim launches new trivalent poultry vaccine, includes protection against H5 avian influenza
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer provides update on iclepertin Phase III program in schizophrenia
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
From Boehringer Ingelheim Limited
Via GlobeNewswire
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
From Boehringer Ingelheim Limited
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.